文献速递前列腺癌

开发新型列线图识别仅接受mpMRI和靶向穿刺活检患者中扩大盆腔淋巴结清扫的候选者

Development of a novel nomogram to identify the candidate to extended pelvic lymph node dissection in patients who underwent mpMRI and target biopsy only.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2022-06-24

本研究回顾性纳入2014年4月至2020年3月期间术前mpMRI阳性且仅接受靶向穿刺活检后行机器人辅助根治性前列腺切除术及扩大盆腔淋巴结清扫的患者461例,其中52例(11.27%)存在淋巴结侵犯。基于临床分期、MRI精囊侵犯、穿刺Gleason评分和PSA构建的列线图可预测淋巴结侵犯风险,评分高于60分(对应风险7%)时识别为候选者。

要点

  • 列线图基于DRE、PI-RADS、精囊侵犯、PSA和靶向病灶Gleason评分预测淋巴结侵犯风险。
  • 模型AUC为0.74(95%CI 0.67-0.81),校准图显示模型接近理想曲线。
  • 列线图评分高于60分(对应淋巴结侵犯风险7%)可识别候选者。

核心结论

  • 列线图仅纳入临床分期、MRI精囊侵犯、穿刺Gleason评分和PSA,评分高于7%时可识别淋巴结侵犯风险患者。

研究设计与样本

  • 回顾性提取2014年4月至2020年3月术前mpMRI阳性且仅接受靶向穿刺活检后行机器人辅助根治性前列腺切除术及扩大盆腔淋巴结清扫的患者数据。
  • 共纳入461例患者,其中52例(11.27%)存在淋巴结侵犯。
  • 采用逻辑回归模型评估术前和术中因素对淋巴结侵犯风险的影响,并以受试者工作特征曲线下面积(AUC)评估模型区分度,基于逻辑模型生成列线图及其校准图。
  • 使用相似队列对模型进行验证。

主要发现

  • 多变量分析显示DRE、PI-RADS、精囊侵犯、PSA和靶向病灶I和II的最差Gleason评分是淋巴结侵犯的显著预测因子。
  • 模型AUC为0.74(95%CI 0.67-0.81)。
  • 校准图显示模型非常接近理想曲线,且位于95%CI内。
  • 通过约登指数设定列线图评分60分为截断值,对应淋巴结侵犯风险为7%。
  • 模型在相似队列中应用的似然比阳性(LH+)为2.58(95%CI 2.17-2.98)。

关键数值与推荐

  • 列线图评分高于60分对应淋巴结侵犯风险7%,可识别淋巴结侵犯风险患者。
  • 模型AUC为0.74(95%CI 0.67-0.81)。
  • 验证队列LH+为2.58(95%CI 2.17-2.98)。

临床怎么用

  • 对于术前mpMRI阳性且仅接受靶向穿刺活检的患者,列线图评分高于60分(对应风险7%)时可识别为扩大盆腔淋巴结清扫的候选者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nowadays a tool able to predict the risk of lymph-node invasion (LNI) in patients underwent target biopsy (TB) only before radical prostatectomy (RP) is still lacking. Our aim is to develop a model based on mp-MRI and target biopsy (TB) alone able to predict the risk of LNI. METHODS: We retrospectively extracted data of patients with preoperative positive mp-MRI and TB only who underwent RARP with ePLND from April 2014 to March 2020. A logistic regression model was performed to evaluate the impact of pre- and intra-operative factors on the risk of LNI. Model discrimination was assessed using an area under (AUC) the ROC curve. A nomogram, and its calibration plot, to predict the risk of LNI were generated based on the logistic model. A validation of the model was done using a similar cohort. RESULTS: 461 patients were included, of which 52 (11.27) had LNI. After logistic regression analysis and multivariable model DRE, PI-RADS, seminal vesicle invasion, PSA and worst GS at I and II target lesions were significant predictors of LNI. The AUC was 0.74 [0.67-0.81] 95% CI. The calibration plot shows that our model is very close to the ideal one which is in the 95% CI. After the creation of a visual nomogram, the cut-off to discriminate between the risk or not of LNI was set with Youden index at 60 points that correspond to a risk of LNI of 7%. The model applied on a similar cohort shown a LH+ of 2.58 [2.17-2.98] 95% CI. CONCLUSIONS: Our nomogram for patients undergoing MRI-TB only takes into account clinical stage, SVI at MRI, biopsy Gleason pattern and PSA and it is able to identify patients with risk of LNI when a score higher than 7% is achieved.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Fiori C, Checcucci E, Stura I, et al. Development of a novel nomogram to identify the candidate to extended pelvic lymph node dissection in patients who underwent mpMRI and target biopsy only. Prostate Cancer Prostatic Dis. 2022. PMID: 35750851. doi:10.1038/s41391-022-00565-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。